AAL
American Airlines Group Inc.
AAL lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to grow, though they disagree widely on how much.
EOSE
Eos Energy Enterprises, Inc.
There isn't enough reported data to score EOSE yet.
AAL Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Under pressure | |
| Weak |
AAL's revenue is currently healthy, but its profitability, cash flow and balance sheet are under pressure.
EOSE Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
EOSE's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
AAL PE Valuation
AAL has no meaningful PE right now: it lost money over the past year.
EOSE PE Valuation
EOSE has no meaningful PE right now: it lost money over the past year.
AAL Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Growth | |
| Weakening | |
| Limited | |
| Low |
Analysts expect AAL's losses to grow, with revenue growing. However, they disagree widely on these estimates.
EOSE Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect EOSE's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
AAL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.73 | -176% |
| Q2 2026 | -$0.49 | -154% |
| Q1 2026 | $0.31 | -69% |
| Q4 2025 | $0.17 | -86% |
| Q3 2025 | $0.96 | +118% |
| Q2 2025 | $0.90 | +$1.06 |
| Q1 2025 | $1.00 | +41% |
| Q4 2024 | $1.24 | +2.5% |
AAL has the stronger earnings trend. Trailing diluted EPS is down 176% for AAL versus EOSE down 224%.
EOSE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2023 | -$2.69 | +$0.85 |
| Q2 2023 | -$3.76 | -$1.00 |
| Q1 2023 | -$3.65 | -$0.86 |
| Q4 2022 | -$3.68 | -$1.32 |
| Q3 2022 | -$3.54 | +$5.19 |
EOSE is still losing money, but less than at its worst: $4.55 per share over the past year, against $8.73 at its worst in late 2021.
AAL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $16.3B | +19% |
| Q2 2026 | $16.7B | +16% |
| Q1 2026 | $13.9B | +11% |
| Q4 2025 | $14B | +2.5% |
| Q3 2025 | $13.7B | +0.3% |
| Q2 2025 | $14.4B | +0.4% |
| Q1 2025 | $12.6B | -0.2% |
| Q4 2024 | $13.7B | +4.6% |
AAL's revenue has grown year over year for six quarters in a row: $16.3B last quarter, up 19% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 0.7% | -0.4 points |
| Q2 2026 | 2.7% | -5.2 points |
| Q1 2026 | -0.3% | +1.9 points |
| Q4 2025 | 3.2% | -5.1 points |
| Q3 2025 | 1.1% | +0.5 points |
| Q2 2025 | 7.9% | -1.8 points |
| Q1 2025 | -2.1% | -2.2 points |
| Q4 2024 | 8.3% | +3.3 points |
AAL has the edge over EOSE on profitability, with a higher operating margin.
EOSE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $82.7M | +171% |
| Q2 2026 | $68.8M | +351% |
| Q1 2026 | $57M | +445% |
| Q4 2025 | $58M | +700% |
| Q3 2025 | $30.5M | +3473% |
| Q2 2025 | $15.2M | +1597% |
| Q1 2025 | $10.5M | +58% |
| Q4 2024 | $7.3M | +9.7% |
EOSE has the edge over AAL on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -96% | +105 points |
| Q2 2026 | -122% | +297 points |
| Q1 2026 | -139% | +367 points |
| Q4 2025 | -140% | +573 points |
| Q3 2025 | -201% | +6044 points |
| Q2 2025 | -419% | +2815 points |
| Q1 2025 | -506% | +117 points |
| Q4 2024 | -713% | -74 points |
EOSE's operating margin was โ96% last quarter, up 105 points from the same quarter a year ago, near the top of its range since 2019.
AAL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.2B | -$376M |
| Q2 2026 | -$351M | -176% |
| Q1 2026 | $3.4B | +109% |
| Q4 2025 | -$1.9B | -$1.6B |
| Q3 2025 | -$872M | -$681M |
| Q2 2025 | $464M | -2.7% |
| Q1 2025 | $1.6B | +20% |
| Q4 2024 | -$342M | +$1.9B |
AAL has the edge over EOSE on cash flow, with more consistent year-over-year improvement.
EOSE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$105.1M | -$22.4M |
| Q2 2026 | -$107.4M | -$34.3M |
| Q1 2026 | -$154.8M | -$121M |
| Q4 2025 | -$75.2M | -$19.5M |
| Q3 2025 | -$82.7M | -$28.5M |
| Q2 2025 | -$73.2M | -$40.6M |
| Q1 2025 | -$33.8M | +$10.7M |
| Q4 2024 | -$55.8M | -$10.2M |
EOSE has burned cash in almost every quarter: โ$443M over the past year, against โ$246M the year before.
AAL Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 9.8x | High |
| Q2 2026 | 9.6x | High |
| Q1 2026 | 7.4x | High |
| Q4 2025 | 8.3x | High |
| Q3 2025 | 6.8x | High |
| Q2 2025 | 7.2x | High |
| Q1 2025 | 6.7x | High |
| Q4 2024 | 6.5x | High |
AAL's net debt is about 9.8 years of its operating earnings (EBITDA), up from 6.8 years a year ago.
EOSE Net Leverage
EOSE's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
AAL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.8 | Neutral |
| Stochastic | 28.9 | Neutral |
AAL's weekly RSI is 49 (neutral) and its Stochastic is 29 (neutral).
EOSE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.5 | Neutral |
| Stochastic | 7.4 | Oversold |
EOSE's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
AAL PE vs Industrials Sector
| Metric | AAL | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 24x | โ |
AAL has no meaningful PE right now: it lost money over the past year.
EOSE PE vs Industrials Sector
EOSE has no meaningful PE right now: it lost money over the past year.
AAL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $12.8 | 3.7% above |
| 20 week MA | $14.0 | 4.8% below |
| 50 week MA | $13.8 | 3.3% below |
| 100 week MA | $13.3 | 0.2% below |
| 200 week MA | $13.6 | 1.8% below |
AAL has the edge over EOSE on trend strength, trading above more of its moving averages.
EOSE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.24 | 19% below |
| 20 week MA | $3.28 | 45% below |
| 50 week MA | $7.01 | 74% below |
| 100 week MA | $7.10 | 75% below |
| 200 week MA | $4.53 | 60% below |
EOSE is in a downtrend: it's below all five of its weekly moving averages, and 60% below its 200-week average.
AAL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $28.4 | $15.7 | -45% |
| 2021 | $15.7 | $18.3 | +17% |
| 2022 | $18.3 | $12.7 | -30% |
| 2023 | $12.7 | $13.7 | +8.1% |
| 2024 | $13.7 | $17.4 | +26% |
| 2025 | $17.4 | $15.4 | -11% |
| 2026 YTD | $15.4 | $13.3 | -14% |
AAL has the edge over EOSE on returns for 2026, with the stronger performance.
EOSE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.72 | $19.2 | +98% |
| 2021 | $19.2 | $8.57 | -55% |
| 2022 | $8.57 | $1.08 | -87% |
| 2023 | $1.08 | $1.09 | +0.9% |
| 2024 | $1.09 | $5.17 | +374% |
| 2025 | $5.17 | $11.9 | +129% |
| 2026 YTD | $11.9 | $1.81 | -85% |
EOSE's yearly returns have swung widely, from +374% in 2024 to โ87% in 2022. It's down 85% so far in 2026.